Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

[Antibiotic consumption and its costs of purchase in Polish neonatology networks units].

Rózańska A, Wójkowska-Mach J, Borszewska-Kornacka M, Cmiel A, Gadzinowski J, Gulczyńska E, Helwich E, Kordek A, Pawlik D, Szczapa J, Heczko PB.

Przegl Epidemiol. 2012;66(3):513-9. Polish.

2.

Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001-2002.

Kern WV, de With K, Steib-Bauert M, Fellhauer M, Plangger A, Probst W; MABUSE-INTERREGIO-II Project Team.

Infection. 2005 Oct;33(5-6):333-9.

PMID:
16258863
3.

Effects of legal antibiotic restrictions on consumption of broad-spectrum beta-lactam antibiotics, glycopeptides and amphotericin B.

Kurt H, Karabay O, Birengel S, Memikoglu O, Yılmaz Bozkurt G, Yalçı A.

Chemotherapy. 2010;56(5):359-63. doi: 10.1159/000321553. Epub 2010 Oct 7.

PMID:
20926859
4.

Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced.

Meyer E, Buttler J, Schneider C, Strehl E, Schroeren-Boersch B, Gastmeier P, Ruden H, Zentner J, Daschner FD, Schwab F.

J Antimicrob Chemother. 2007 Jun;59(6):1148-54. Epub 2007 Apr 13.

PMID:
17434880
5.

Variation in antibiotic use in neonatal intensive care units in the Netherlands.

Liem TB, Krediet TG, Fleer A, Egberts TC, Rademaker CM.

J Antimicrob Chemother. 2010 Jun;65(6):1270-5. doi: 10.1093/jac/dkq107. Epub 2010 Apr 7.

PMID:
20375032
6.

Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007.

Dumartin C, L'Hériteau F, Péfau M, Bertrand X, Jarno P, Boussat S, Angora P, Lacavé L, Saby K, Savey A, Nguyen F, Carbonne A, Rogues AM.

J Antimicrob Chemother. 2010 Sep;65(9):2028-36. doi: 10.1093/jac/dkq228. Epub 2010 Jun 25.

PMID:
20581121
7.

Antibiotic consumption in laboratory confirmed vs. non-confirmed bloodstream infections among very low birth weight neonates in Poland.

Różańska A, Wójkowska-Mach J, Adamski P, Borszewska-Kornacka M, Gulczyńska E, Nowiczewski M, Helwich E, Kordek A, Pawlik D, Bulanda M.

Ann Clin Microbiol Antimicrob. 2017 Mar 31;16(1):20. doi: 10.1186/s12941-017-0196-y.

8.
9.

Update on glycopeptide use in german university hospitals.

Kern WV, De With K, Gonnermann C, Strehl E, Bergner J, Höffken G, Dörje F, Daschner F, Steib-Bauert M, Haber M, Herrmann M, Hartmann M, Straube E, Bühner R, Rothe U, Salzberger B, Marre R, Kern P; Medical Antibiotic Use Surveillance and Evaluation.

Infection. 2004 Jun;32(3):157-62.

PMID:
15188076
10.

Intensive care unit drug utilization in a teaching hospital in Nepal.

Shankar PR, Partha P, Dubey AK, Mishra P, Deshpande VY.

Kathmandu Univ Med J (KUMJ). 2005 Apr-Jun;3(2):130-7.

PMID:
16415608
11.

Antibiotic utilization prevalence: prospective comparison between two medical departments in a tertiary care university hospital.

Gendel I, Azzam ZS, Braun E, Levy Y, Krivoy N.

Pharmacoepidemiol Drug Saf. 2004 Oct;13(10):735-9.

PMID:
15386728
12.

[Use of systemic antibacterial agents at a university emergency clinic in Bucharest, in the year 2008].

Ion-Nedelcu N, Radu L, Firulescu S, Truţă E, Sîrbu M, Barbu G, Calistru P.

Bacteriol Virusol Parazitol Epidemiol. 2009 Jan-Mar;54(1):53-8. Romanian.

PMID:
20524396
13.

Necrotising enterocolitis in preterm infants: epidemiology and antibiotic consumption in the Polish neonatology network neonatal intensive care units in 2009.

Wójkowska-Mach J, Różańska A, Borszewska-Kornacka M, Domańska J, Gadzinowski J, Gulczyńska E, Helwich E, Kordek A, Pawlik D, Szczapa J, Heczko PB.

PLoS One. 2014 Mar 21;9(3):e92865. doi: 10.1371/journal.pone.0092865. eCollection 2014.

14.

[Evolution of antibiotic consumption in an intensive care burn department].

Thabet L, Bousselmi K, Oueslati S, Memmi M, Ben Redjeb S, Messadi AA.

Tunis Med. 2007 Dec;85(12):1035-8. French.

PMID:
19170383
15.

Economic implications of neonatal intensive care unit collaborative quality improvement.

Rogowski JA, Horbar JD, Plsek PE, Baker LS, Deterding J, Edwards WH, Hocker J, Kantak AD, Lewallen P, Lewis W, Lewit E, McCarroll CJ, Mujsce D, Payne NR, Shiono P, Soll RF, Leahy K.

Pediatrics. 2001 Jan;107(1):23-9.

PMID:
11134429
16.

Methodological validation of monitoring indicators of antibiotics use in hospitals.

Mandy B, Koutny E, Cornette C, Woronoff-Lemsi MC, Talon D.

Pharm World Sci. 2004 Apr;26(2):90-5.

PMID:
15085943
17.

[Costs of intensive care of premature infants].

Krawczyk-Wyrwicka I, Piotrowski A, Rydlewska-Liszkowska I, Hanke W.

Przegl Epidemiol. 2006;60(1):155-62. Polish.

PMID:
16758755
18.

Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.

Nicasio AM, Eagye KJ, Kuti EL, Nicolau DP, Kuti JL.

Pharmacotherapy. 2010 May;30(5):453-62. doi: 10.1592/phco.30.5.453.

PMID:
20411997
19.

[Implementation of antimicrobial resistance surveillance and antibiotic consumption in an intensive care burn department].

Messadi AA, Thabet L, Bousselmi K, Oueslati S, Ben Redjeb S.

Tunis Med. 2008 May;86(5):486-9. French.

PMID:
19469305
20.

Analysis of non-hospital antibacterial pharmacotherapy in Poland.

Dziurda D, Polak S, Skowron A, Kuschill-Dziurda J, Brandys J.

Int J Infect Dis. 2008 Sep;12(5):483-9. doi: 10.1016/j.ijid.2007.12.014. Epub 2008 Apr 15.

Supplemental Content

Support Center